Gibson, Dunn & Crutcher advised Intel Corporation on the offering, and Davis Polk & Wardwell advised the joint book-running managers. Intel Corporation (Intel) (Nasdaq:INTC) announced its $2.55...
Intel’s $2.55 Billion Senior Notes Offering
UCT’s Acquisition of HIS Innovations Group
Davis Polk & Wardwell advised Ultra Clean Holdings, Inc. on the transaction. Ultra Clean Holdings, Inc. (UCT) announced its acquisition of HIS Innovations Group. UCT paid $50...
DexCom’s $1.25 Billion Convertible Notes Offering and Capped Call Transactions
Fenwick advised DexCom on the offering, while Davis Polk advised the representatives of the initial purchasers and the counterparties to the capped call transactions. DexCom, Inc....
Revolution Medicines’ $345 Million Common Stock Public Offering
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
Natera’s $400 Million Shares Offering
Davis Polk advised the representatives of the several underwriters in the offering. Natera, Inc. announced its follow-on offering of 11,430,000 shares of common stock for total gross...